0
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Original Article |  May 01, 2012 FREE
Cost-effectiveness of a Multicondition Collaborative Care Intervention:  A Randomized Controlled Trial
Wayne Katon, MD; Joan Russo, PhD; Elizabeth H. B. Lin, MD, MPH; et al.
Arch Gen Psychiatry. 2012;69(5):506-514. doi:10.1001/archgenpsychiatry.2011.1548.
Original Article |  January 01, 2010 FREE
Metabolic Testing Rates in 3 State Medicaid Programs After FDA Warnings and ADA/APA Recommendations for Second-Generation Antipsychotic Drugs
Elaine H. Morrato, DrPH, MPH; Benjamin Druss, MD, MPH; Daniel M. Hartung, PharmD, MPH; et al.
Arch Gen Psychiatry. 2010;67(1):17-24. doi:10.1001/archgenpsychiatry.2009.179.
Original Article |  February 01, 2005 FREE
Do Statins Reduce Risk of Incident Dementia and Alzheimer Disease?:  The Cache County Study
Peter P. Zandi, PhD; D. Larry Sparks, PhD; Ara S. Khachaturian, PhD; et al.
Arch Gen Psychiatry. 2005;62(2):217-224. doi:10.1001/archpsyc.62.2.217.
Original Article |  November 01, 2002 FREE
An Assessment of the Independent Effects of Olanzapine and Risperidone Exposure on the Risk of Hyperlipidemia in Schizophrenic Patients
Carol E. Koro, PhD; Donald O. Fedder, DrPH; Gilbert J. L'Italien, PhD; et al.
Arch Gen Psychiatry. 2002;59(11):1021-1026. doi:10.1001/archpsyc.59.11.1021.
Original Article |  December 01, 2001 FREE
Clozapine Use in Patients With Schizophrenia and the Risk of Diabetes, Hyperlipidemia, and Hypertension:  A Claims-Based Approach
Brian C. Lund, PharmD; Paul J. Perry, PhD; John M. Brooks, PhD; et al.
Arch Gen Psychiatry. 2001;58(12):1172-1176. doi:10.1001/archpsyc.58.12.1172.
Original Article |  May 01, 1999 FREE
Omega 3 Fatty Acids in Bipolar Disorder:  A Preliminary Double-blind, Placebo-Controlled Trial
Andrew L. Stoll, MD; W. Emanuel Severus, MD, PhD; Marlene P. Freeman, MD; et al.
Arch Gen Psychiatry. 1999;56(5):407-412. doi:10.1001/archpsyc.56.5.407.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Viewpoint  |  May 6, 2013
Two New Drugs for Homozygous Familial Hypercholesterolemia:  Managing Benefits and Risks in a Rare Disorder
Robert J. Smith, MD; William R. Hiatt, MD
JAMA Internal Medicine
Research Letters  |  April 29, 2013
Limit to Benefits of Large Reductions in Low-Density Lipoprotein Cholesterol Levels: Use of Fractional Polynomials to Assess the Effect of Low-Density Lipoprotein Cholesterol Level Reduction in Metaregression of Large Statin Randomized Trials
Hisato Takagi, MD, PhD; Takuya Umemoto, MD, PhD; for the ALICE (All-Literature Investigation of Cardiovascular Evidence) Group
JAMA Internal Medicine
Invited Commentary  |  March 4, 2013
Getting to the Heart of HIV and Myocardial Infarction:  Comment on “HIV Infection and the Risk of Acute Myocardial Infarction”
Patrick W. G. Mallon, MB, BCh, PhD, FRACP, FRCPI
JAMA Internal Medicine
Research Letters  |  April 08, 2013
A National Survey of the Treatment of Hyperlipidemia in Primary Prevention
Michael E. Johansen, MD; Katherine J. Gold, MD, MSW, MS; Ananda Sen, PhD; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems